Global Market for Healthcare Analytics to Approach $15B by 2022
November 09, 2017
WELLESLEY, Mass., Nov 9, 2017 – As healthcare transitions from a provider to a consumer-driven model, there is increasing demand for analytic tools to meet high expectations. In a new study, BCC Research examines the global market for healthcare analytics (forecast to reach $14.9 billion by 2022) by applications, end users and regions.
Healthcare analytics is a growing force in the global healthcare IT market and a major sector driving the entire healthcare industry. Healthcare analytics is the next step following the inception of electronic medical records to facilitate the meaningful use of data. With margin pressures increasing worldwide, analytics are regarded as a tool to reduce costs. From less than $7.2 billion in 2017, worldwide growth is predicted at a compound annual growth rate (CAGR) of 15.8%, according to the report Healthcare Analytics: Technologies and Global Markets.
Market restraints include lack of uniformity in healthcare data, resistance to an IT-based approach by medical professionals, an operational gap between the payer and provider fronts and the need to ensure patient confidentiality.
Research Highlights
- The U.S. government, a major market in terms of value, is fueling the market for healthcare analytics with its Affordable Care Act and reimbursements.
- The highest growth (28.2%) is projected to stem from population health analytics, as the healthcare industry places greater emphasis on this segment than it has in previous years.
- With the use of predictive analytics, clinical analytics is expected to be the second fastest-growing segment.
“Technology is changing rapidly and, as innovations are adopted, they are having a positive impact on the healthcare analytics market,” said Robert G. Hunter, senior editor, healthcare. “Payer-provider convergence and rising healthcare costs, along with the other market drivers, are creating many opportunities that are boosting the global healthcare analytics market.”
North America Dominates Global Market
With 50% of the market, North America accounts for the largest share of the global healthcare analytics market. This region is expected to grow at a CAGR of 15.3% during the forecast period of 2017–2022, which is followed by Europe with a 23% share and Asia with 18%. The Rest of the World represents a 9% share.
Editors/reporters requesting analyst interviews should contact steven.cumming@bccresearch.com.
Healthcare Analytics: Technologies and Global Markets( HLC187B )
Publish Date: Oct 2017
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
- Global Patient Monitoring Market to Reach $55.8 Billion by End of 2030
Reports from Health Maintenance
Recent News
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
- Global GLP-1 Analogues Market to Reach $268.4 Billion by 2030
- Global Botanical and Plant-Derived Drug Market Projected to Hit $58.1 Billion by 2030